Skip to main content

Bradley J. Katz, MD, PhD

Languages spoken: English

Academic Information

Departments: Ophthalmology/Visual Sciences - Professor, Neurology - Adjunct Professor

Divisions: Headache and Neuro-Ophthalmology

Academic Office Information

Bradley.Katz@hsc.utah.edu

Board Certification

  • National Board of Medical Examiners
Bradley Katz, MD, PhD, provides medical and surgical care of eye conditions including cataract, glaucoma, diabetes, and macular degeneration at the John A. Moran Eye Center, University of Utah, Salt Lake City. He specializes in neuro-ophthalmology and evaluates patients with diseases that affect the optic nerve, diseases that affect eye movements and neurologic diseases that affect vision. Dr. Katz’s research interests center around include light sensitivity (“photophobia”) and neurologic conditions associated with light sensitivity, such as migraine and blepharospasm.

Education History

Fellowship University of Utah School of Medicine
Neuro-Ophthalmology
Fellow
Residency University of Iowa Hospitals and Clinics
Ophthalmology
Resident
Internship University of Illinois at Urbana - Champaign
Internal Medicine
Intern
Doctoral Training University of Illinois at Urbana - Champaign
Neuroscience
Ph.D.
Professional Medical University of Illinois at Urbana - Champaign
M.D.
Undergraduate Northwestern University
Biomedical Engineering
B.S.
Undergraduate Northwestern University
Electrical Engineering
B.S.

Selected Publications

  1. Katz BJ (2020). Put a Drop of Timolol Into Each Eye and Call Me in the Morning. JAMA Ophthalmol.
  2. Orme DR, Vegunta S, Miller MA, Warner JEA, Bair C, McFadden M, Crum AV, Digre KB, Katz BJ (2020). A Comparison Between the Clinical Features of Pseudotumor Cerebri Secondary to Tetracyclines and Idiopathic Intracranial Hypertension. Am J Ophthalmol, 220, 177-182.
  3. Sibony PA, Biousse V, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser CL, Huna-Baron R, Katz B, Lawlor M, Malmqvist L, Newman NJ, Peragallo J, Petzold A, Subramanian PS, Warner JEA, Wegener M, Wong S, Hamann S, ODDS Consortium (2020). Comment on: Morphologic Features of Buried Optic Disc Drusen on En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography. [Letter to the editor]. Am J Ophthalmol, 219, 369-370.
  4. Hamann S, Malmqvist L, Wegener M, Biousse V, Bursztyn L, Citirak G, Costello F, Crum AV, Digre K, Fard MA, Fraser JA, Huna-Baron R, Katz B, Lawlor M, Newman NJ, Peragallo JH, Petzold A, Sibony PA, Subramanian PS, Warner JE, Wong SH, Fraser CL, Optic Disc Drusen Studies Consortium (2020). Young Adults with Anterior Ischemic Optic Neuropathy: A Multicenter Optic Disc Drusen Study. Am J Ophthalmol, 217, 174-181.
  5. Ozudogru S, Neufeld A, Katz BJ, Baggaley S, Pippitt K, Zhang Y, Digre KB (2019). Reduced Visual Quality of Life Associated with Migraine is Most Closely Correlated with Symptoms of Dry Eye. Headache, 59(10), 1714-1721.
  6. Cortez MM, Digre K, Uddin D, Hung M, Blitzer A, Bounsanga J, Voss MW, Katz BJ (2019). Validation of a photophobia symptom impact scale. Cephalalgia, 39(11), 1445-1454.
  7. Blair S, Katz BJ (2019). Apparatus and methods for reducing frequency or severity of photophobic responses or modulating circadian cycles. U.S. Patent No. PCT/US2012/021500. Washington, D.C.:U.S. Patent and Trademark Office.
  8. Katz BJ (2018). Optic Nerve Head Drusen: The Relationship Between Intraocular Pressure and Optic Nerve Structure and Function: Comment. J Neuroophthalmol, 39(1), 143.
  9. Malmqvist L, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser C, Katz B, Lawlor M, Petzold A, Sibony P, Warner J, Wegener M, Wong S, Hamann S (2018). Peripapillary Hyperreflective Ovoid Mass-Like Structures: Is It Optic Disc Drusen or Not?: Response. [Letter to the editor]. J Neuroophthalmol, 38(4), 568-570.
  10. Hu JY, Katz B (2018). Non-arteritic ischemic optic neuropathy and supplemental nitric oxide usage. Am J Ophthalmol Case Rep, 11, 26-27.
  11. Bowen RC, Koeppel JN, Christensen CD, Snow KB, Ma J, Katz BJ, Krauss HR, Landau K, Warner JEA, Crum AV, Straumann D, Digre KB (2018). The Most Common Causes of Eye Pain at 2 Tertiary Ophthalmology and Neurology Clinics. J Neuroophthalmol, 38(3), 320-327.
  12. Malmqvist L, Bursztyn L, Costello F, Digre K, Fraser JA, Fraser C, Katz B, Lawlor M, Petzold A, Sibony P, Warner J, Wegener M, Wong S, Hamann S (2018). The Optic Disc Drusen Studies Consortium Recommendations for Diagnosis of Optic Disc Drusen Using Optical Coherence Tomography. J Neuroophthalmol, 38(3), 299-307.
  13. Hanson LL, Ahmed Z, Katz BJ, Warner JEA, Crum AV, Zhang Y, Zhang Y, Baggaley S, Pippitt K, Cortez MM, Digre KB (2018). Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life. Headache, 58(7), 1007-1013.
  14. Adesina OO, Scott McNally J, Salzman KL, Katz BJ, Warner JEA, McFadden M, Digre KB (2018). Diffusion-Weighted Imaging and Post-contrast Enhancement in Differentiating Optic Neuritis and Non-arteritic Anterior Optic Neuropathy. Neuroophthalmology, 42(2), 90-98.
  15. Blackburn MK, Lamb RD, Digre KB, Smith AG, Warner JE, McClane RW, Nandedkar SD, Langeberg WJ, Holubkov R, Katz BJ (2008). FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology, 116(5), 997-1001.
  16. Crow RW, Katz BJ, Warner JE, Alder SC, Zhang K, Schulman S, Digre KB (2009). Giant cell arteritis and mortality. J Gerontol A Biol Sci Med Sci, 64(3), 365-9.
  17. Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley SK, Katz BJ (2009). A comparison of idiopathic intracranial hypertension with and without papilledema. Headache, 49(2), 185-93.
  18. Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB (2008). A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Retina, 28(10), 1478-86.
  19. Payne M, Yang Z, Katz BJ, Warner JE, Weight CJ, Zhao Y, Pearson ED, Treft RL, Hillman T, Kennedy RJ, Meire FM, Zhang K (2004). Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. Am J Ophthalmol, 138(5), 749-55.